Breast cancer has multiple molecular subtypes that are classified using tumor biomarkers, such as hormone receptors (HR) (i.e., estrogen receptor (ER) and progesterone receptor (PR)) and human epidermal growth factor receptor 2 (Her2) [3]. This evidence concerns the gene PGR and breast cancer.